Header Logo

Connection

Daniel Skiest to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Daniel Skiest has written about Cost-Benefit Analysis.
Daniel Skiest
Connection Strength
0.040
Cost-Benefit Analysis
  1. Keiser P, Nassar N, Kvanli MB, Turner D, Smith JW, Skiest D. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs. J Acquir Immune Defic Syndr. 2001 May 01; 27(1):14-9.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.